Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

Market Cap	2.70B
Revenue (ttm)	1.07B
Net Income (ttm)	27.84M
Shares Out	303.35M
EPS (ttm)	0.09
PE Ratio	96.91
Forward PE	n/a
Dividend	0.04 (0.45%)
Ex-Dividend Date	n/a

Volume	12,076,000
Average Volume	30,150,634
Open	9.20
Previous Close	9.02
Day's Range	8.90 - 9.20
52-Week Range	6.85 - 11.06
Beta	0.48
RSI	46.59
Earnings Date	Aug 22, 2025

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells Chinese patent medicines, health food, and APIs in China and internationally. The company offers Xuanfei Zhicough mixture, Yuanhu Zhitong dropping pills, Qiwei Wenyang capsules, Maxing cough capsule, and Astragalus Angelica capsules. Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD was founded in 2002 and is based in Lanzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 634
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300534

Financial Performance

In 2024, SHE:300534's revenue was 1.04 billion, a decrease of -3.79% compared to the previous year's 1.08 billion. Earnings were 25.80 million, a decrease of -58.14%.